Report Detail
Global and Japan Insulin Syringes Market Insights, Forecast to 2026
- RnM4203521 |
- 14 September, 2020 |
- Global |
- 144 Pages |
- QYResearch |
- Pharma & Healthcare
Insulin Syringes market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Syringes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Insulin Syringes market is segmented into
3/10 cc syringe
1/2 cc syringe
1 cc syringe
Others
Segment by Application, the Insulin Syringes market is segmented into
Hospital
Homecare
Others
Regional and Country-level Analysis
The Insulin Syringes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Syringes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Syringes Market Share Analysis
Insulin Syringes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Syringes business, the date to enter into the Insulin Syringes market, Insulin Syringes product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
1 Study Coverage
- 1.1 Insulin Syringes Product Introduction
- 1.2 Market Segments
- 1.3 Key Insulin Syringes Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Insulin Syringes Market Size Growth Rate by Type
- 1.4.2 3/10 cc syringe
- 1.4.3 1/2 cc syringe
- 1.4.4 1 cc syringe
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Insulin Syringes Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Homecare
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insulin Syringes Market Size, Estimates and Forecasts
- 2.1.1 Global Insulin Syringes Revenue 2015-2026
- 2.1.2 Global Insulin Syringes Sales 2015-2026
- 2.2 Global Insulin Syringes, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Insulin Syringes Historical Market Size by Region (2015-2020)
- 2.3.1 Global Insulin Syringes Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Insulin Syringes Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Insulin Syringes Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Insulin Syringes Sales Forecast by Region (2021-2026)
- 2.4.2 Global Insulin Syringes Revenue Forecast by Region (2021-2026)
3 Global Insulin Syringes Competitor Landscape by Players
- 3.1 Global Top Insulin Syringes Sales by Manufacturers
- 3.1.1 Global Insulin Syringes Sales by Manufacturers (2015-2020)
- 3.1.2 Global Insulin Syringes Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Insulin Syringes Manufacturers by Revenue
- 3.2.1 Global Insulin Syringes Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Insulin Syringes Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Insulin Syringes Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Insulin Syringes Revenue in 2019
- 3.2.5 Global Insulin Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Insulin Syringes Price by Manufacturers
- 3.4 Global Insulin Syringes Manufacturing Base Distribution, Product Types
- 3.4.1 Insulin Syringes Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insulin Syringes Product Type
- 3.4.3 Date of International Manufacturers Enter into Insulin Syringes Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Insulin Syringes Market Size by Type (2015-2020)
- 4.1.1 Global Insulin Syringes Sales by Type (2015-2020)
- 4.1.2 Global Insulin Syringes Revenue by Type (2015-2020)
- 4.1.3 Insulin Syringes Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Insulin Syringes Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Insulin Syringes Sales Forecast by Type (2021-2026)
- 4.2.2 Global Insulin Syringes Revenue Forecast by Type (2021-2026)
- 4.2.3 Insulin Syringes Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Insulin Syringes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Insulin Syringes Market Size by Application (2015-2020)
- 5.1.1 Global Insulin Syringes Sales by Application (2015-2020)
- 5.1.2 Global Insulin Syringes Revenue by Application (2015-2020)
- 5.1.3 Insulin Syringes Price by Application (2015-2020)
- 5.2 Insulin Syringes Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Insulin Syringes Sales Forecast by Application (2021-2026)
- 5.2.2 Global Insulin Syringes Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Insulin Syringes Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Insulin Syringes Market Size YoY Growth 2015-2026
- 6.1.1 Japan Insulin Syringes Sales YoY Growth 2015-2026
- 6.1.2 Japan Insulin Syringes Revenue YoY Growth 2015-2026
- 6.1.3 Japan Insulin Syringes Market Share in Global Market 2015-2026
- 6.2 Japan Insulin Syringes Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Insulin Syringes Players by Sales (2015-2020)
- 6.2.2 Japan Top Insulin Syringes Players by Revenue (2015-2020)
- 6.3 Japan Insulin Syringes Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Insulin Syringes Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Insulin Syringes Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Insulin Syringes Price by Type (2015-2020)
- 6.4 Japan Insulin Syringes Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Insulin Syringes Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Insulin Syringes Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Insulin Syringes Price Forecast by Type (2021-2026)
- 6.5 Japan Insulin Syringes Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Insulin Syringes Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Insulin Syringes Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Insulin Syringes Price by Application (2015-2020)
- 6.6 Japan Insulin Syringes Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Insulin Syringes Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Insulin Syringes Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Insulin Syringes Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Insulin Syringes Market Size YoY Growth 2015-2026
- 7.2 North America Insulin Syringes Market Facts & Figures by Country
- 7.2.1 North America Insulin Syringes Sales by Country (2015-2020)
- 7.2.2 North America Insulin Syringes Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Insulin Syringes Market Size YoY Growth 2015-2026
- 8.2 Europe Insulin Syringes Market Facts & Figures by Country
- 8.2.1 Europe Insulin Syringes Sales by Country
- 8.2.2 Europe Insulin Syringes Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Insulin Syringes Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Insulin Syringes Market Facts & Figures by Country
- 9.2.1 Asia Pacific Insulin Syringes Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Insulin Syringes Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Insulin Syringes Market Size YoY Growth 2015-2026
- 10.2 Latin America Insulin Syringes Market Facts & Figures by Country
- 10.2.1 Latin America Insulin Syringes Sales by Country
- 10.2.2 Latin America Insulin Syringes Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Insulin Syringes Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Insulin Syringes Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Insulin Syringes Sales by Country
- 11.2.2 Middle East and Africa Insulin Syringes Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Novo Nordisk
- 12.1.1 Novo Nordisk Corporation Information
- 12.1.2 Novo Nordisk Description and Business Overview
- 12.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Novo Nordisk Insulin Syringes Products Offered
- 12.1.5 Novo Nordisk Recent Development
- 12.2 Sanofi
- 12.2.1 Sanofi Corporation Information
- 12.2.2 Sanofi Description and Business Overview
- 12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Sanofi Insulin Syringes Products Offered
- 12.2.5 Sanofi Recent Development
- 12.3 Eli Lilly and Company
- 12.3.1 Eli Lilly and Company Corporation Information
- 12.3.2 Eli Lilly and Company Description and Business Overview
- 12.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Eli Lilly and Company Insulin Syringes Products Offered
- 12.3.5 Eli Lilly and Company Recent Development
- 12.4 Biocon Ltd
- 12.4.1 Biocon Ltd Corporation Information
- 12.4.2 Biocon Ltd Description and Business Overview
- 12.4.3 Biocon Ltd Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Biocon Ltd Insulin Syringes Products Offered
- 12.4.5 Biocon Ltd Recent Development
- 12.5 Ypsomed AG
- 12.5.1 Ypsomed AG Corporation Information
- 12.5.2 Ypsomed AG Description and Business Overview
- 12.5.3 Ypsomed AG Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Ypsomed AG Insulin Syringes Products Offered
- 12.5.5 Ypsomed AG Recent Development
- 12.6 Wockhardt Ltd
- 12.6.1 Wockhardt Ltd Corporation Information
- 12.6.2 Wockhardt Ltd Description and Business Overview
- 12.6.3 Wockhardt Ltd Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Wockhardt Ltd Insulin Syringes Products Offered
- 12.6.5 Wockhardt Ltd Recent Development
- 12.7 Medtronic Plc
- 12.7.1 Medtronic Plc Corporation Information
- 12.7.2 Medtronic Plc Description and Business Overview
- 12.7.3 Medtronic Plc Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Medtronic Plc Insulin Syringes Products Offered
- 12.7.5 Medtronic Plc Recent Development
- 12.8 Abbott Laboratories
- 12.8.1 Abbott Laboratories Corporation Information
- 12.8.2 Abbott Laboratories Description and Business Overview
- 12.8.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Abbott Laboratories Insulin Syringes Products Offered
- 12.8.5 Abbott Laboratories Recent Development
- 12.9 Animas Corporation
- 12.9.1 Animas Corporation Corporation Information
- 12.9.2 Animas Corporation Description and Business Overview
- 12.9.3 Animas Corporation Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Animas Corporation Insulin Syringes Products Offered
- 12.9.5 Animas Corporation Recent Development
- 12.10 F. Hoffmann-La Roche
- 12.10.1 F. Hoffmann-La Roche Corporation Information
- 12.10.2 F. Hoffmann-La Roche Description and Business Overview
- 12.10.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 F. Hoffmann-La Roche Insulin Syringes Products Offered
- 12.10.5 F. Hoffmann-La Roche Recent Development
- 12.11 Novo Nordisk
- 12.11.1 Novo Nordisk Corporation Information
- 12.11.2 Novo Nordisk Description and Business Overview
- 12.11.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Novo Nordisk Insulin Syringes Products Offered
- 12.11.5 Novo Nordisk Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Insulin Syringes Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insulin Syringes Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Insulin Syringes. Industry analysis & Market Report on Insulin Syringes is a syndicated market report, published as Global and Japan Insulin Syringes Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Insulin Syringes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
